These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21720510)

  • 1. Enhanced effect and mechanism of water-in-oil microemulsion as an oral delivery system of hydroxysafflor yellow A.
    Qi J; Zhuang J; Wu W; Lu Y; Song Y; Zhang Z; Jia J; Ping Q
    Int J Nanomedicine; 2011; 6():985-91. PubMed ID: 21720510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in rats.
    Wang S; Sun M; Ping Q
    Int J Pharm; 2008 Jun; 358(1-2):198-204. PubMed ID: 18417306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced absorption of hydroxysafflor yellow A using a self-double-emulsifying drug delivery system: in vitro and in vivo studies.
    Lv LZ; Tong CQ; Lv Q; Tang XJ; Li LM; Fang QX; Yu J; Han M; Gao JQ
    Int J Nanomedicine; 2012; 7():4099-107. PubMed ID: 22888246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal Delivery of Compounds with Different Lipophilicity and Molecular Weight from W/O Microemulsions Analyzed by UPLC-QTOF/ MS and LC-MS/MS.
    Lin H; Michniak-Kohn B; Xia Z; Xu L; Kang Q; Chen C; Ma S; Wu Q
    Curr Drug Deliv; 2018; 15(7):1009-1019. PubMed ID: 29268684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of effect of water-in-oil microemulsion as an oral delivery system for fexofenadine: in vitro and in vivo studies.
    Gundogdu E; Alvarez IG; Karasulu E
    Int J Nanomedicine; 2011; 6():1631-40. PubMed ID: 21904453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of enhanced oral absorption of hydrophilic drug incorporated in hydrophobic nanoparticles.
    Lv LZ; Tong CQ; Yu J; Han M; Gao JQ
    Int J Nanomedicine; 2013; 8():2709-17. PubMed ID: 23935363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel formulation design of self-emulsifying drug delivery systems (SEDDS) type O/W microemulsion I: enhancing effects on oral bioavailability of poorly water soluble compounds in rats and beagle dogs.
    Araya H; Nagao S; Tomita M; Hayashi M
    Drug Metab Pharmacokinet; 2005 Aug; 20(4):244-56. PubMed ID: 16141604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved oral bioavailability of poorly water-soluble glimepiride by utilizing microemulsion technique.
    Li H; Pan T; Cui Y; Li X; Gao J; Yang W; Shen S
    Int J Nanomedicine; 2016; 11():3777-88. PubMed ID: 27540291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and in vitro-in vivo evaluation of a water-in-oil microemulsion formulation for the oral delivery of troxerutin.
    Xu M; Yu Q; Zhao Q; Chen W; Lin Y; Jin Y
    Drug Dev Ind Pharm; 2016; 42(2):280-7. PubMed ID: 26165244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral bioavailability enhancement of raloxifene by developing microemulsion using D-optimal mixture design: optimization and in-vivo pharmacokinetic study.
    Shah N; Seth A; Balaraman R; Sailor G; Javia A; Gohil D
    Drug Dev Ind Pharm; 2018 Apr; 44(4):687-696. PubMed ID: 29168671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel oral preparation of hydroxysafflor yellow A base on a chitosan complex: a strategy to enhance the oral bioavailability.
    Ma GN; Yu FL; Wang S; Li ZP; Xie XY; Mei XG
    AAPS PharmSciTech; 2015 Jun; 16(3):675-82. PubMed ID: 25511808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A.
    Zhao B; Gu S; Du Y; Shen M; Liu X; Shen Y
    Int J Pharm; 2018 Jan; 535(1-2):164-171. PubMed ID: 29107614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanisms for enhanced oral absorption of hydroxysafflor yellow A by chuanxiong volatile oil.
    Qi J; Sun M; Ping Q; Zhuang J; Li J; Peddie F; Song Y
    Planta Med; 2010 May; 76(8):786-92. PubMed ID: 20033864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach.
    Tang TT; Hu XB; Liao DH; Liu XY; Xiang DX
    Int J Nanomedicine; 2013; 8():4415-26. PubMed ID: 24277986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of a self-nanoemulsifying drug delivery system loaded with Akebia saponin D-phospholipid complex.
    Shen J; Bi J; Tian H; Jin Y; Wang Y; Yang X; Yang Z; Kou J; Li F
    Int J Nanomedicine; 2016; 11():4919-4929. PubMed ID: 27713630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of dl-praeruptorin A microemulsion based hydrogel for dermal delivery.
    Zhang X; Wu Y; Hong Y; Zhu X; Lin L; Lin Q
    Drug Deliv; 2015; 22(6):757-64. PubMed ID: 24724963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability.
    Hu L; Yang J; Liu W; Li L
    Drug Deliv; 2011 Jan; 18(1):90-5. PubMed ID: 20942639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower irritation microemulsion-based rotigotine gel: formulation optimization and in vitro and in vivo studies.
    Wang Z; Mu HJ; Zhang XM; Ma PK; Lian SN; Zhang FP; Chu SY; Zhang WW; Wang AP; Wang WY; Sun KX
    Int J Nanomedicine; 2015; 10():633-44. PubMed ID: 25609965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization and relative bioavailability of oral elemene o/w microemulsion.
    Zeng Z; Zhou G; Wang X; Huang EZ; Zhan X; Liu J; Wang S; Wang A; Li H; Pei X; Xie T
    Int J Nanomedicine; 2010 Sep; 5():567-72. PubMed ID: 20856831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel formulation design of O/W microemulsion for improving the gastrointestinal absorption of poorly water soluble compounds.
    Araya H; Tomita M; Hayashi M
    Int J Pharm; 2005 Nov; 305(1-2):61-74. PubMed ID: 16219433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.